Cargando…

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has considerably increased over the last years. NAFLD is currently the most common cause of chronic liver disease in the developing world. The diagnosis of NAFLD/NASH is often incidental, as the earl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Głuszyńska, Paulina, Lemancewicz, Dorota, Dzięcioł, Janusz Bogdan, Razak Hady, Hady
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706342/ https://www.ncbi.nlm.nih.gov/pubmed/34945016 http://dx.doi.org/10.3390/jcm10245721

Ejemplares similares

The Effect of Laparoscopic Sleeve Gastrectomy on the Course of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients during One Year of Follow Up
por: Głuszyńska, Paulina, et al.
Publicado: (2023)

Nutritional optic neuropathy following bariatric surgery
por: Sawicka-Pierko, Anna, et al.
Publicado: (2014)

Risk Factors for Early and Late Complications after Laparoscopic Sleeve Gastrectomy in One-Year Observation
por: Głuszyńska, Paulina, et al.
Publicado: (2022)

The impact of bariatric surgery on nutritional status of patients
por: Jastrzębska-Mierzyńska, Marta, et al.
Publicado: (2015)

In-and-Out Molecular Changes Linked to the Type 2 Diabetes Remission after Bariatric Surgery: An Influence of Gut Microbes on Mitochondria Metabolism
por: Samczuk, Paulina, et al.
Publicado: (2018)

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Korean Patients Undergoing Bariatric Surgery
por: Kim, Ki Hyun, et al.
Publicado: (2022)

The influence of patient’s age on metabolic and bariatric results of laparoscopic sleeve gastrectomy in 2-year observation
por: Woźniewska, Paulina, et al.
Publicado: (2020)

Resveratrol Relaxes Human Gastric Smooth Muscles Through High Conductance Calcium-Activated Potassium Channel in a Nitric Oxide-independent Manner
por: Modzelewska, Beata, et al.
Publicado: (2022)

Assessment of dietary habits, nutritional status and blood biochemical parameters in patients prepared for bariatric surgery: a preliminary study
por: Jastrzębska-Mierzyńska, Marta, et al.
Publicado: (2012)

Clusters of Glycemic Response to Oral Glucose Tolerance Tests Explain Multivariate Metabolic and Anthropometric Outcomes of Bariatric Surgery in Obese Patients
por: Szczerbinski, Lukasz, et al.
Publicado: (2019)

Assessment of education effects on patient involvement and bariatric treatment outcome: an observational study
por: Sierżantowicz, Regina, et al.
Publicado: (2019)

ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)

Complications associated with laparoscopic sleeve gastrectomy – a review
por: Woźniewska, Paulina, et al.
Publicado: (2021)

Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease
por: Kirkpatrick, Kennedy, et al.
Publicado: (2021)

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Saeed, Ali, et al.
Publicado: (2017)

The Influence of Laparoscopic Sleeve Gastrectomy on Metabolic Syndrome Parameters in Obese Patients in Own Material
por: Hady, Hady Razak, et al.
Publicado: (2011)

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
por: Lemancewicz, Dorota, et al.
Publicado: (2012)

Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery
por: Yuan, Xianwen, et al.
Publicado: (2018)

Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study
por: Wei, Luyang, et al.
Publicado: (2021)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Oxidative Modification of Biomolecules in the Nonstimulated and Stimulated Saliva of Patients with Morbid Obesity Treated with Bariatric Surgery
por: Fejfer, Katarzyna, et al.
Publicado: (2017)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Carneros, David, et al.
Publicado: (2020)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2023)

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
por: Sasaki, Akira, et al.
Publicado: (2014)

Phase angle and non-alcoholic fatty liver disease before and after bariatric surgery
por: Teixeira, Joise, et al.
Publicado: (2020)

Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
por: Geerts, Anja, et al.
Publicado: (2023)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
por: Gangopadhyay, Anwesha, et al.
Publicado: (2022)

Revisional operations among patients after surgical treatment of obesity: a multicenter Polish Revision Obesity Surgery Study (PROSS)
por: Major, Piotr, et al.
Publicado: (2022)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Savic, Dragana, et al.
Publicado: (2020)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?
por: Juárez-Hernández, Eva, et al.
Publicado: (2022)

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
por: Laursen, Tea L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4cmb73v3m7t8gcph0i55hpi6ul